SCHEMBL26459720

SCHEMBL26459720

Nc1ccc2cc(S(=O)(=O)O)cc(O)c2c1/N=N\c1ccc(-c2ccc(/N=N\c3c(N)ccc4cc(S(=O)(=O)O)cc(O)c34)cc2)cc1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SUMO2 P61956 2/20 0.72
▸ SUMO1 P63165 2/20 0.72
▸ SENP7 Q9BQF6 2/20 0.72
▸ SENP2 Q9HC62 2/20 0.72
▸ ENPP2 Q13822 5/20 0.68
▸ APEX1 P27695 2/20 0.51
▸ CYP1A2 P05177 2/20 0.50
▸ CYP2C9 P11712 2/20 0.50
▸ NT5E P21589 2/20 0.50
▸ CYP2C19 P33261 1/20 0.50
▸ HSD17B10 Q99714 1/20 0.50
▸ PHLPP2 Q6ZVD8 3/20 0.48
▸ PRMT1 Q99873 1/20 0.45
▸ MEN1 O00255 1/20 0.45
▸ HTT P42858 1/20 0.45
▸ KMT2A Q03164 1/20 0.45
▸ CDK1 P06493 1/20 0.43
▸ CDK2 P24941 1/20 0.43
▸ SENP3 Q9H4L4 1/20 0.43
▸ SENP1 Q9P0U3 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14418348 1.00 SUMO2 (0.72) SUMO2SUMO1SENP7SENP2ENPP2
SCHEMBL26459322 0.94 SUMO2 (0.65) SUMO2SUMO1SENP7SENP2ENPP2
SCHEMBL25511892 0.94 SUMO2 (0.65) SUMO2SUMO1SENP7SENP2ENPP2
SCHEMBL11765859 0.94 SUMO2 (0.81) SUMO2SUMO1SENP7SENP2ENPP2
SCHEMBL11765850 0.94 SUMO2 (0.81) SUMO2SUMO1SENP7SENP2ENPP2
SCHEMBL10941468 0.93 SUMO2 (0.72) SUMO2SUMO1SENP7SENP2ENPP2
SCHEMBL10941472 0.93 SUMO2 (0.72) SUMO2SUMO1SENP7SENP2ENPP2
SCHEMBL11670234 0.91 SUMO2 (0.74) SUMO2SUMO1SENP7SENP2ENPP2
SCHEMBL11670202 0.90 SUMO2 (0.72) SUMO2SUMO1SENP7SENP2ENPP2
SCHEMBL7790539 0.90 SENP2 (0.68) SUMO2SUMO1SENP7SENP2ENPP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230127304-A1 NEW INHIBITORS FOR THE KEAP1-NRF2 PROTEIN-PROTEIN INTERACTION PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2023-04-27 — — US disclosed
US-20230127304-A1 NEW INHIBITORS FOR THE KEAP1-NRF2 PROTEIN-PROTEIN INTERACTION PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2023-04-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230127304-A1 NEW INHIBITORS FOR THE KEAP1-NRF2 PROTEIN-PROTEIN INTERACTION KEAP1, HMOX1, NFE2L2 SUMO2 1521/4885SUMO1 1055/4885SENP7 3092/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback